Oppenheimer Holdings Stock News

It took 179 years after the New York Stock Exchange was established in 1792 for a Black investment firm to take a seat. And while there were already Black financiers and businessmen such as Americas first Black millionaire, Jeremiah G. Hamilton , who died in 1875, there are others who set the groundwork for todays generation of Black Wall Street brokers and financiers. Here are 11 who were among the first to break through on Wall Street. Thorvald McGregor and Lawrence Lewis : Each of these men is credited from different sources as being the first registered Black securities salesmen. McGregor worked at Mercer Hicks, Lewis for Abraham & Company. Norman L. McGhee: In 1952, he founded the first Black securities firm, McGhee & Company, which obtained a NASD license. McGhee: Screenshot of "Black History Month 2021" WKYC via YouTube Lilla St. John: She was the first Black woman to pass the NYSE exam in 1953 to work for Oppenheimer & Company. See Also: Maggie Lena Walker: Celebrating A Barrier-Smashing Financial Pioneer Harry L.

Oppenheimer has downgraded Homology Medicines (FIXX) to perform following the company''s announcement that the FDA imposed a clinical hold on its pheNIX gene therapy trial of HMI-102.

SAN RAMON, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO ), will present at Oppenheimer''s 32 nd Annual Healthcare Conference on Wednesday, March 16, 2022. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual session scheduled to begin at 3:20 PM ET. A live webcast of the presentation will be available to all interested parties on the … Full story available on Benzinga.com

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to present at the Oppenheimer 32nd Annual Virtual Healthcare Conference on Wednesday, March 16, 2022 at 2:00 p.m. Eastern Time. John Martins, Group President Delivery, and William J. Burns, Executive Vice President & Chief Financial Officer, will be attending the conference. An audio webcast and presentation for this conference will be available on the Compan

Oppenheimer is sticking up for Digital Turbine stock (APPS -12.3%) - caught in a downdraft coming from Google''s initiative to cut back advertising tracking on its Android mobile…

Amgen had its price target increased by Oppenheimer from $272.00 to $285.00 in a report released on Wednesday morning, Price Targets.com reports. They currently have an

Oppenheimer Holdings (NYSE:OPY) had declared $0.15/share quarterly dividend, in line with previous.Payable Feb. 25; for shareholders of record Feb. 11; ex-div Feb.

4Q22 earnings impacted by lower incentive income on alternative investments. Capital market division has record results.

Jason Helfstein, Oppenheimer managing director of internet equity research, joins ''Power Lunch'' to discuss Meta''s quarterly earnings results and how investors should play the stock.

Oppenheimer has upgraded shares of NovoCure from perform to outperform citing the company current valuation and growth from the release of next-generation arrays mid

Lodging firm Sonder Holdings Inc. (SOND) rose 6.5% after receiving a new outperform rating at Oppenheimer after going public following a de-spacing last month. "We see SOND''s broad

Following more than 18% rise on Friday in reaction to its announcement on the FDA approval of Omnipod 5, Insulet <> is extending gains after Oppenheimer upgraded the stock

Oppenheimer Holdings press release (OPY): Q4 GAAP EPS of $4.61.Revenue of $365.11M (-13.7% Y/Y).

Citi, Goldman, JPMorgan Urge Investors To BTFD Is the worst behind us? According to strategists from Goldman Sachs, Citi, JPMorgan, and BofA (selectively), it is time to buy-the-f**king-dip. The market is experiencing a correction within an ongoing bull market cycle according to Goldman''s Peter Oppenheimer Any further significant weakness at the index level should be seen as a buying opportunity, in our view, The key thing for equities from here is how much any of this shift upward in interest rate expectations and indeed in financial conditions will hit growth, Goldmans Oppenheimer said in an interview with Bloomberg Television. Thats going to be key to determine where equity markets stabilize. Specifically, Goldman notes that their Risk Appetite Indicator (GSRAII) has fallen back, suggesting we are getting closer to levels that have typically been a good entry point for longer-term investors. Goldman warns that the biggest risk is that high valuations will continue to unwind should real rates rise much further, but they note the crucial determinant is what is happening to growth .